Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.6061/clinics/2020/e2353 http://scihub22266oqcxt.onion/10.6061/clinics/2020/e2353 33263635!7688073!33263635     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clinics+(Sao+Paulo) 2020 ; 75 (ä): e2353 Nephropedia Template TP {{tp|p=33263635|t=2020. Update on the diagnosis and management of COVID-19 in pediatric patients |pdf=|usr=}}{{33263635}} gab.com Text Update on the diagnosis and management of COVID-19 in pediatric patients JO: Clinics (Sao Paulo) http://www.kidney.de/pget.php?&tw=1&pmid=33263635 #FOAvip Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), became a pandemic in March 2020, affecting millions of people worldwide. However, COVID-19 in pediatric patients represents 1-5% of all cases, and the risk for developing severe disease and critical illness is much lower in children with COVID-19 than in adults. Multisystem inflammatory syndrome in children (MIS-C), a possible complication of COVID-19, has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease or toxic shock syndrome in children with evidence of SARS-CoV-2 infection. This review presents an update on the diagnostic methods for COVID-19, including reverse-transcriptase polymerase chain reaction (RT-PCR) tests, serology tests, and imaging, and summarizes the current recommendations for the management of the disease. Particular emphasis is placed on respiratory support, which includes noninvasive ventilation and invasive mechanical ventilation strategies according to lung compliance and pattern of lung injury. Pharmacological treatment, including pathogen-targeted drugs and host-directed therapies, has been addressed. The diagnostic criteria and management of MIS-C are also summarized. Twit Text FOAVip Update on the diagnosis and management of COVID-19 in pediatric patients ????Clinics (Sao Paulo) http://www.kidney.de/pget.php?&tw=1&pmid=33263635 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33263635 #FOAvip English Wikipedia <ref>{{Cite pmid|33263635}}</ref> Update on the diagnosis and management of COVID-19 in pediatric patients #MMPMID33263635 Carlotti APCP; de Carvalho WB; Johnston C; Gilio AE; de Sousa Marques HH; Ferranti JF; Rodriguez IS; Delgado AF Clinics (Sao Paulo) 2020[]; 75 (ä): e2353 PMID33263635show ga Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), became a pandemic in March 2020, affecting millions of people worldwide. However, COVID-19 in pediatric patients represents 1-5% of all cases, and the risk for developing severe disease and critical illness is much lower in children with COVID-19 than in adults. Multisystem inflammatory syndrome in children (MIS-C), a possible complication of COVID-19, has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease or toxic shock syndrome in children with evidence of SARS-CoV-2 infection. This review presents an update on the diagnostic methods for COVID-19, including reverse-transcriptase polymerase chain reaction (RT-PCR) tests, serology tests, and imaging, and summarizes the current recommendations for the management of the disease. Particular emphasis is placed on respiratory support, which includes noninvasive ventilation and invasive mechanical ventilation strategies according to lung compliance and pattern of lung injury. Pharmacological treatment, including pathogen-targeted drugs and host-directed therapies, has been addressed. The diagnostic criteria and management of MIS-C are also summarized. |*COVID-19 Drug Treatment[MESH] |*COVID-19/therapy[MESH] |*Systemic Inflammatory Response Syndrome/therapy[MESH] |Child[MESH] |Humans[MESH] |Pandemics[MESH]Update on the diagnosis and management of COVID-19 in pediatric patien(epmc).pdf DeepDyve Pubget Overpricing